Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Travis

Showing results (11-20 of 166) with videos related to

Pageof 17
Sort By:
International Journal of Nanomedicine|August 29, 2007
Targeting nanomedicines in the treatment of Crohn's disease: focus on certolizumab pegol (CDP870)Lotte Dinesen, Simon Travis
Journal of Crohn'S & Colitis|February 14, 2016
Swallowing anti-TNFα in Ulcerative Colitis: Potentially More Gain Than PainAlessandro Armuzzi, Simon Travis
Journal of Crohn'S & Colitis|April 3, 2012
Leading change in inflammatory bowel disease. ForewordDaniel Hommes, Simon Travis
Inflammatory Bowel Diseases|February 25, 2009
Incidence and clinical significance of immunogenicity to infliximab in Crohn's disease: a critical systematic reviewAndrea Cassinotti, Simon Travis
Inflammatory Bowel Diseases|September 26, 2008
Is IBD associated with a stressful lifestyle?P Dunckley, Simon Travis
Gastroenterology|November 21, 2022
Shining a Light on Barrier FunctionMatthias Friedrich, Simon Travis
Gastroenterology & Hepatology|March 3, 2023
Why Studying Urgency Is UrgentJulia Pakpoor, Simon Travis
Intestinal Research|August 10, 2018
What's app? Electronic health technology in inflammatory bowel diseaseAlissa Walsh, Simon Travis
Gastroenterology|May 3, 2011
Conventional medical management of inflammatory bowel diseaseDaniel Burger, Simon Travis
Gastroenterology & Hepatology|March 28, 2014
Assessing disease activity in patients with ulcerative colitisAlissa Walsh, Simon Travis
Pageof 17

Showing results (11-20 of 166) with videos related to

Sort By:
Pageof 17
International Journal of Nanomedicine|August 29, 2007
Targeting nanomedicines in the treatment of Crohn's disease: focus on certolizumab pegol (CDP870)Lotte Dinesen, Simon Travis
Journal of Crohn'S & Colitis|February 14, 2016
Swallowing anti-TNFα in Ulcerative Colitis: Potentially More Gain Than PainAlessandro Armuzzi, Simon Travis
Journal of Crohn'S & Colitis|April 3, 2012
Leading change in inflammatory bowel disease. ForewordDaniel Hommes, Simon Travis
Inflammatory Bowel Diseases|February 25, 2009
Incidence and clinical significance of immunogenicity to infliximab in Crohn's disease: a critical systematic reviewAndrea Cassinotti, Simon Travis
Inflammatory Bowel Diseases|September 26, 2008
Is IBD associated with a stressful lifestyle?P Dunckley, Simon Travis
Gastroenterology|November 21, 2022
Shining a Light on Barrier FunctionMatthias Friedrich, Simon Travis
Gastroenterology & Hepatology|March 3, 2023
Why Studying Urgency Is UrgentJulia Pakpoor, Simon Travis
Intestinal Research|August 10, 2018
What's app? Electronic health technology in inflammatory bowel diseaseAlissa Walsh, Simon Travis
Gastroenterology|May 3, 2011
Conventional medical management of inflammatory bowel diseaseDaniel Burger, Simon Travis
Gastroenterology & Hepatology|March 28, 2014
Assessing disease activity in patients with ulcerative colitisAlissa Walsh, Simon Travis
Pageof 17